Er-Ping Xu

Er-Ping Xu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
PSPan Su
Pan Su
MWMengdi Wu
Mengdi Wu
XYXiaoting Yin
Xiaoting Yin
MLMengyuan Li
Mengyuan Li
YLYu Cheng Li
Yu Cheng Li
EXEr-Ping Xu
Er-Ping Xu

23 February 2022 in Brain Research
Verified
Journal Article
Closed access
CZChangjing Zhang
Changjing Zhang
LZLeilei Zhu
Leilei Zhu
SLShuaifei Lu
Shuaifei Lu
MLMengyuan Li
Mengyuan Li
MBMing Bai
Ming Bai
EXEr-Ping Xu
Er-Ping Xu

3 November 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YWYuanyuan Wang
Yuanyuan Wang
BZBo Zhang
Bo Zhang
SLSiqi Liu
Siqi Liu
EXEr-Ping Xu
Er-Ping Xu
ZWZhibin Wang
Zhibin Wang

1 January 2020 in Pharmaceutical Biology
Verified
Journal Article
Open access
YLYucheng Li
Yucheng Li
BWBaoying Wang
Baoying Wang
JSJiduo Shen
Jiduo Shen
MBMing Bai
Ming Bai
EXEr-Ping Xu
Er-Ping Xu
Context: Berberine is an alkaloid that possesses various pharmacologic effects. Objective: To explore the mechanism of berberine to improve insulin sensitivity in fructose-fed mice. Materials and methods: Sixty male ICR mice were randomly divided into 6 groups (10 mice in each group): control, fructose, pioglitazone (10 mg/kg) and berberine (50, 100, and 200 mg/kg). Except for the control group, the mice received 20% fructose drinking for 10 weeks. Pioglitazone and berberine were orally administered once daily during the last 4 weeks. The insulin sensitivity was evaluated using an oral glucose tolerance test (OGTT). The serum levels of fasting glucose and insulin, blood lipids, and hormones were determined. The hepatic AMP and ATP contents were detected using high performance liquid chromatography (HPLC) analysis, and the protein expression was examined by immunoblotting. Results: Berberine significantly reversed the insulin resistance induced by fructose, including lowering fasting insulin levels (from 113.9 to 67.4) and area under the curve (AUC) during OGTT (from 1310 to 1073), decreasing serum leptin (from 0.28 to 0.13) and increasing serum adiponectin levels (from 1.50 to 2.80). Moreover, berberine enhanced the phosphorylation levels of protein kinase B (PKB/AKT; 2.27-fold) and glycogen synthase kinase-3β (GSK3β; 2.56-fold), and increased hepatic glycogen content (from 0.19 to 1.65). Furthermore, berberine upregulated the protein expression of peroxisome proliferator activated receptor gamma coactivator 1α (PGC1α; 2.61-fold), phospho-AMP-activated protein kinase (p-AMPK; 1.35-fold) and phospho-liver kinase B1 (p-LKB1; 1.41-fold), whereas it decreased the AMP/ATP ratio (from 4.25 to 1.82). Conclusion: The present study demonstrated the protective effects of berberine against insulin resistance induced by fructose. Our findings may provide an experimental basis for the application of berberine in the treatment of insulin resistance.


21 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
PWPei Wang
Pei Wang
JCJun Chi
Jun Chi
HGHui Guo
Hui Guo
SWShun-Xiang Wang
Shun-Xiang Wang
JWJing Wang
Jing Wang
ZWzhi-min wang
zhi-min wang
Cinnamomi ramulus (CR) and Cinnamomi cortex (CC), both sourced from Cinnamomum cassia Presl, are commonly used Chinese medicines in the Chinese Pharmacopeia. However, while CR functions to dissipate cold and to resolve external problems of the body, CC functions to warm the internal organs. To clarify the material basis of these different functions and clinical effects, a simple and reliable UPLC-Orbitrap-Exploris-120-MS/MS method combined with multivariate statistical analyses was established in this study with the aim of exploring the difference in chemical compositions of aqueous extracts of CR and CC. As the results indicated, a total of 58 compounds was identified, including nine flavonoids, 23 phenylpropanoids and phenolic acids, two coumarins, four lignans, four terpenoids, 11 organic acids and five other components. Of these compounds, 26 significant differential compounds were identified statistically including six unique components in CR and four unique components in CC. Additionally, a robust HPLC method combined with hierarchical clustering analysis (HCA) was developed to simultaneously determine the concentrations and differentiating capacities of five major active ingredients in CR and CC: coumarin, cinnamyl alcohol, cinnamic acid, 2-methoxycinnamic acid and cinnamaldehyde. The HCA results showed that these five components could be used as markers for successfully distinguishing CR and CC. Finally, molecular docking analyses were conducted to obtain the affinities between each of the abovementioned 26 differential components, focusing on targets involved in diabetes peripheral neuropathy (DPN). The results indicated that the special and high-concentration components in CR showed high docking scores of affinities with targets such as HbA1c and proteins in the AMPK–PGC1–SIRT3 signaling pathway, suggesting that CR has greater potential than CC for treating DPN.